PYMNTS.com March 18, 2025
Generative artificial intelligence (GenAI) is rapidly transitioning from a futuristic concept to a tangible force reshaping the healthcare landscape.
Buoyed by early successes, healthcare firms are aggressively increasing their investments in GenAI, particularly in areas like product innovation and customer service, signaling a shift in how the industry operates.
A report from PYMNTS Intelligence, “Healthcare Firms Going Long on GenAI Investment,” reveals that these bets are already yielding significant returns, prompting a wave of further adoption among major players.
The report surveyed C-suite executives at healthcare firms with at least $1 billion in annual revenue to understand their GenAI strategies.
The findings indicate a strong conviction in the technology’s potential, with nine in 10 executives anticipating a positive return on...
Today's Sponsors
Today's Sponsor